Inovio Pharmaceuticals In...
(INO)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Net Income | -135.12M | -279.82M | -303.66M | -167.47M | -120.55M | -96.97M | -88.21M | -73.74M | -29.10M | -36.14M | -66.08M | -19.71M | -15.30M | -17.64M | -24.46M | -12.97M | -11.20M | -12.48M | -15.30M | -11.26M | -6.59M | -5.96M | -8.64M | -9.60M | -6.60M |
| Depreciation & Amortization | 3.50M | 5.50M | 4.73M | 4.63M | 5.52M | 5.00M | 3.47M | 3.09M | 1.92M | 1.57M | 2.10M | 1.99M | 2.01M | 2.11M | 1.68M | 993.03K | 954.64K | 911.64K | 799.32K | 573.04K | 584.41K | 619.34K | 655.50K | 566.36K | 400.00K |
| Stock-Based Compensation | 11.07M | 22.56M | 26.34M | 15.65M | 10.90M | 10.65M | 13.07M | 10.48M | 6.19M | 5.43M | 1.87M | 1.35M | 1.65M | 1.17M | 2.16M | 1.14M | 1,702.80B | 1.40M | 116.38K | 413.32K | 170.96K | 105.41K | 226.00K | - | - |
| Other Working Capital | 26.40M | -9.07M | -2.37M | -2.15M | -1.92M | 2.64M | -10.40M | 823.13K | 10.53M | 233.91K | 3.21M | -109.10K | -744.38K | 2.87M | -5.67M | -87.52K | -99.81K | 3.64M | -30.30K | 3.24M | 38.91K | 87.63K | -199.43K | 155.03K | 100.00K |
| Other Non-Cash Items | 38.48M | 11.69M | 858.64K | 2.36M | 10.09M | -360.80K | 5.71M | -1.83M | -3.00M | -2.88M | 45.03M | -4.77M | -6.89M | -1.28M | 11.10M | 63.00B | -1,639.80B | 238.97K | 3.36M | 647.65K | 3.22M | -5.81M | -49.56K | 109.18K | 100.00K |
| Deferred Income Tax | -32.05M | 4.03M | 5.67M | 37.93M | -260.82K | 3.42M | -150.03K | -849 | -2.08M | 27.54K | 32.27K | 22.81K | 53.19K | 53.19K | -887.25K | -63.00B | -63.00B | -63.00K | -57.75K | -413.32K | -170.96K | 5.86M | -226.00K | - | - |
| Change in Working Capital | -10.26M | 19.83M | 50.35M | -71.07M | -3.54M | 4.71M | 2.90M | -546.16K | 13.64M | 2.17M | 1.67M | -1.19M | -1.28M | 3.65M | -3.67M | -187.02K | -640.54K | 2.95M | -1.26M | 3.24M | 38.91K | 232.70K | -336.09K | 133.67K | -200.00K |
| Operating Cash Flow | -124.37M | -216.22M | -215.71M | -177.98M | -97.85M | -73.55M | -63.21M | -62.56M | -12.44M | -29.82M | -15.38M | -22.31M | -19.76M | -11.94M | -14.08M | -11.13M | -11.51M | -7.04M | -12.34M | -6.80M | -2.75M | -4.96M | -8.37M | -8.79M | -6.30M |
| Capital Expenditures | -320.90K | -969.15K | -1.23M | -1.52M | -987.93K | -2.09M | -10.29M | -3.94M | -2.78M | -1.38M | -176.93K | -240.99K | -161.19K | -306.63K | -164.94K | -583.80K | -645.73K | -1.37M | -286.91K | -102.36K | -59.62K | -408.71K | -263.97K | -289.51K | -500.00K |
| Acquisitions | - | -2.00M | 1,435.80B | 38.73M | 987.93B | 2,779.50B | - | -1.20M | - | 1.38M | - | - | - | -124.98K | 1.61M | -7,416.20B | 645.73B | 1.37M | -2.34M | - | - | - | - | - | - |
| Purchase of Investments | -203.48M | -248.53M | -348.95M | -156.22M | -100.95M | -88.16M | -95.70M | -57.32M | -63.53M | -47.19M | -15.40M | -9.14M | -18.29M | -8.00M | - | -4.50M | -18.60M | -24.00M | - | - | - | - | -2.80M | - | - |
| Sales Maturities Of Investments | 284.93M | 361.08M | 174.84M | 62.99M | 92.89M | 132.66M | 77.16M | 76.53M | 10.48M | 12.75M | 4.34M | 14.01M | 7.21M | 19.71M | - | 8.00M | 16.40M | 9.30M | - | - | - | - | - | - | - |
| Other Investing Acitivies | 6.22M | 110.56M | -1,435.80B | -2.77M | -987.93B | -2,779.50B | 1.00M | 2.20M | 1.00M | -1.38M | 2.00M | 650.00K | 350.00K | 157.48K | 1.45M | 7,416.20B | -645.73B | -1.37M | -447.76K | -336.75K | -280.50K | 19.56K | -320.59K | -495.58K | -300.00K |
| Investing Cash Flow | 87.36M | 109.59M | -175.34M | -58.80M | -9.04M | 42.42M | -27.83M | 16.27M | -54.82M | -35.81M | -9.24M | 5.28M | -10.90M | 11.44M | 1.45M | 2.92M | -2.85M | -16.07M | -3.08M | -439.12K | -340.12K | -389.15K | -3.39M | -785.09K | -800.00K |
| Debt Repayment | - | - | - | 171.62K | 97.44M | - | - | - | - | - | - | - | - | -12.18M | -160.84K | 12.11M | 36.03K | - | - | - | -20.64K | -27.48K | - | -58.33K | -45.89K |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -23.34K | -132.34K | -613.93K | -276.31K | - | - | - | - | - |
| Other Financial Acitivies | -466.65K | -1.11M | 2.06M | 10.62M | -1.14M | 1.81M | 1.34M | 1.49M | 2.45M | 13.25M | 19.81M | - | 15.93K | 168.66K | 358.74K | 50.00K | - | - | - | - | - | 3.92M | 5.74M | 7.39M | 4.93M |
| Financial Cash Flow | 5.00M | 81.84M | 211.50M | 465.28M | 105.40M | 31.04M | 95.69M | 7.79M | 84.35M | 72.46M | 52.69M | 5.33M | 28.01M | -9.69M | 28.60M | 12.16M | 16.30M | 14.19M | 14.69M | 11.67M | 15.67M | 4.59M | 5.74M | 13.13M | 6.90M |
| Net Cash Flow | -32.02M | -24.81M | -179.58M | 228.53M | -1.50M | -92.95K | 4.65M | -38.50M | 17.09M | 6.82M | 28.07M | -11.70M | -2.65M | -10.30M | 16.18M | 3.86M | 1.93M | -8.84M | -723.23K | 4.43M | 12.59M | -937.66K | -6.02M | 3.55M | -300.00K |
| Free Cash Flow | -124.69M | -217.18M | -216.94M | -179.50M | -98.84M | -75.64M | -73.50M | -66.49M | -15.22M | -31.20M | -15.56M | -22.55M | -19.92M | -12.24M | -14.25M | -11.71M | -12.16M | -8.41M | -12.63M | -6.90M | -2.81M | -5.37M | -8.63M | -9.08M | -6.80M |